Navigation Links
Jefferson scientists find protein helps pancreatic cancer cells evade immune system and spread
Date:1/10/2008

on in T-cells, putting them in a resting state, and recruits a different type of immune cell called T-regulatory cells, which can inhibit the immune system. If cells are escaping the primary tumor and going into another environment such as the lymph nodes, what are they doing to evade detection by the immune system? says Dr. Brody. These data point to the fact that IDO may play a role in helping cancer cells avoid the immune system. His team reported its findings at the recent meeting of the Southern Surgical Association in Hot Springs, VA. The results have been accepted for publication in the Journal of the American College of Surgeons.

The group also examined pancreatic cancer cell lines in the laboratory for IDO expression. Using antibodies to IDO, they didnt find any IDO expression until they treated the cells with interferon to mimic the conditions in the lymph nodes. The tumor cells were then able to make the enzyme.

Whether or not the cancer has spread to the lymph nodes can affect a patients prognosis, particularly after surgery. While scientists know a great deal about how a pancreatic cancer develops from a pre-cancerous growth into a cancer, they still dont have a clear understanding of how it progresses from a primary cancer to metastatic disease. IDO, Dr. Brody says, may play an important part in the process.

The immune system appears to have a balance that can allow cancer cells to grow but also can detect and destroy them, Brody explains. While IDO is crucial to regulating this balance, too much IDO tips the balance toward an immune suppression, supporting cancer growth.

Dr. Brody notes that IDO inhibitors are available clinically, and these could in theory be used with chemotherapy or perhaps other forms of immune therapy against pancreatic cancer. An inhibitor might be able to activate T-cells to kill cancer cells, for example. Presumably we could give IDO inhibitors up front to patients who we know are lymph nod
'/>"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer
2. Jefferson vascular surgeon heads national trial for torn aorta repair
3. Jefferson neuroscientists find early lead exposure impedes recovery from brain injury
4. Jefferson scientists see breast cancer gene activity from outside the body
5. Jefferson scientists uncover key pathway, potential drug targets in autoinflammatory disease
6. Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease
7. Jefferson researchers show chemotherapy and radiation together extend lung cancer patients lives
8. Jefferson researchers find stem cells in degenerating spinal discs, potential for repair
9. Jefferson oncologists show focused radiation is effective as surgery against nerve tumor
10. Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
11. MicroRNAs may be key to HIVs ability to hide, evade drugs, Jefferson scientists find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Carvers' goal is to help an ... day in Breck. , Conveniently located in the ... from Breckenridge, this family-owned place since 1995, has ... rentals ( http://www.breckenridgeskishop.com/en/rent-equipment ) and more. , ... in May 2015. With style and function progressing ...
(Date:4/24/2015)... 24, 2015 On February 21st, 2015, ... an interview with ItsNotAboutMe.TV contributor Karen Salkin at Durkin ... treatment center for addiction, of which Wickstrom is the ... throughout the year, the EcoLuxe Lounge is a gathering ... and socially conscious products and services. Among the many ...
(Date:4/24/2015)... Anchor Health Administrators (Anchor), specialists in Long-Term Care ... exclusive agreement with LTC Solutions for All LLC (SFA) ... , Anchor has more than 18 years of experience ... and is currently the designated advocate for the American ... member benefit. , “I am very pleased to be ...
(Date:4/24/2015)... Joseph, Missouri (PRWEB) April 24, 2015 ... for veterinarians , UGA is now proud to be ... the care of 16,000 animals a year. This partnership ... care for their animals. , After providing an ... Missouri Veterinary Medical Teaching Hospital (VMTH) wanted to increase ...
(Date:4/24/2015)... “ Opera ” was featured on NewsWatch as part of ... technology products available to consumers. Andrew Tropeano, a technology expert ... with viewers how this is the fastest way to surf ... not be in existence. But each web browser is slightly ... different. Celebrating their 20th anniversary this year, Opera connects over ...
Breaking Medicine News(10 mins):Health News:Carvers Breckenridge Bike Rentals Offers Demo Mountain, Tandem, Bike Path Cruiser & JR. Bikes in May 2015 2Health News:Karen Salkin Talks with Per Wickstrom at the 2015 EcoLuxe Lounge and the "Salute to the Oscars" Celebration 2Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:A Web Browser That Connects over 350 Million People was Featured on NewsWatch Television 2
... irregularities are at greater risk of heart-rhythm abnormality: study ... who have severe sleep-related breathing problems are at increased ... , The study included 2,911 men who underwent sleep ... episodes of paused or shallow breathing during sleep were ...
... (NYSE: HGR ) announced today that it plans to ... the second quarter ending June 30, 2009, on Tuesday, July 28, ... The conference call is scheduled to begin at 9:00 a.m., EDT, ... 1-800-931-9710. In addition, a replay will be available until August 5, ...
... U.S. patent infringement lawsuit was filed on June 10, ... America, Inc. The lawsuit, brought by Aperio Technologies, ... of Delaware, accuses products incorporating Hamamatsu Photonics K.K. NanoZoomer(R) ... and 7,518,652. , , The lawsuit follows a ...
... YORK, June 23 FamilyCord , one of ... their title sponsorship of the WBLI 106.1 Baby Shower event where ... for a day of fun, prizes, and education on June 28. ... storing cord blood to protect newborns against 70 life-threatening diseases. Leading ...
... June 23 The National Medical Association (NMA) congratulates President ... their work with PhRMA to bring down health care costs ... the adoption of Medicare Part D has been a tremendous ... the system," said Dr. Mohammad N. Akhter, Executive Director of ...
, Journalists and other readers should disregard the news release, PHT Names VP to Lead Sales of A-Claim Payment Solution for Doctors, Hospitals, issued 23-Jun-2009. The release was transmitted prema...
Cached Medicine News:Health News:Sleep Disorders Linked to Arrhythmias 2Health News:U.S. Patent Infringement Lawsuit Filed by Aperio Technologies, Inc. 2
(Date:4/24/2015)... Introduction of new ... tools for radiosurgery/SBRT   The "Elements" ... enhancing the workflow for difficult to treat indications ... - comes full circle with the introduction of ... Elements enable on-the-fly generation of consistent treatment plans ...
(Date:4/24/2015)... , April 24, 2015 /CNW/ - T-Bird Pharma Inc. ... on developing premium quality medical marijuana products and a ... for Medical Purposes Regulations ( Canada ) ... certain of its shareholders, has closed the transaction announced ... Medna has acquired (the "Escrow Transfer") a total of ...
(Date:4/23/2015)... Lifesciences Corporation (NYSE: EW ), the global leader ... today reported net income for the quarter ended March 31, ... Net income for the same period a year earlier ... non-GAAP net income was $82.1 million, or $0.76 per ... ended March 31, 2015 increased 13.0 percent to $590.3 million ...
Breaking Medicine Technology:Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16
... 2011 Pennsylvania Association of Medical Suppliers (PAMS) ... Thompson (R-Centre) and Jason Altmire, (D-Allegheny) that would ... medical equipment.  H.R. 1041, titled the "Fairness in ... patient groups and consumer organizations, including the Three ...
... ViroPharma Incorporated (Nasdaq: VPHM ) today ... Use (CHMP) of the European Medicines Agency (EMA) has ... March 2011 recommending approval of a Centralized Marketing Authorization ... with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention ...
Cached Medicine Technology:Bi-Partisan Legislation Introduced Would Repeal Controversial Medicare 'Competitive Bidding' Requirements for Home Medical Equipment 2Bi-Partisan Legislation Introduced Would Repeal Controversial Medicare 'Competitive Bidding' Requirements for Home Medical Equipment 3Bi-Partisan Legislation Introduced Would Repeal Controversial Medicare 'Competitive Bidding' Requirements for Home Medical Equipment 4ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union 2ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union 3ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union 4ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union 5ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union 6
Suspend® Tutoplast® Processed Fascia Lata is your naturally safe and strong choice for pelvic floor reconstruction. Suspend comes from a dense matrix of collagen bundles and transverse fasc...
... Bard® Dermal Allograft ... of most pelvic floor ... highly resistant to suture ... and serves as a ...
... Viral RNA Mini Kit allows ... from cell-free fluid samples. Examples ... can be isolated with this ... limited to, RNA from hepatitis ...
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe...
Medicine Products: